Valuation: Camurus AB

Market Cap 3.59TCr 364.44Cr 317.79Cr 300.07Cr 272.48Cr 510.52Cr 35TCr 512.65Cr 1.39TCr 18TCr 1.37TCr 1.34TCr 57TCr P/E 2026 *
35.8x
P/E 2027 * 25.5x
Enterprise Value 3.14TCr 318.64Cr 277.85Cr 262.36Cr 238.24Cr 446.36Cr 31TCr 448.23Cr 1.21TCr 16TCr 1.2TCr 1.17TCr 50TCr EV / Sales 2026 *
11x
EV / Sales 2027 * 8.04x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day+2.98%
1 week+2.29%
Current month+3.51%
1 month-1.79%
3 months+13.32%
6 months+28.24%
Current year-1.95%
1 week 574.5
Extreme 574.5
610.5
1 month 571.5
Extreme 571.5
644.5
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
714.5
3 years 293
Extreme 293
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 63 01/01/2002
Chairman 77 01/01/2015
Director/Board Member 61 07/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
07/08/26 Sell

Executive/Senior Manager

-5,800 0.0096%
27/02/26 Sell

Chief Executive Officer

55,550 0.0928%
27/02/26 Sell

Chief Executive Officer

1,500 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
+2.98%+2.29%-12.46%+107.99% 355.47Cr
+0.04%+3.34%+51.12%+101.82% 1,02700Cr
-0.09%+1.66%+55.02%+66.18% 65TCr
-0.02%+2.66%+18.91%+71.47% 47TCr
-1.22%+3.27%+37.02%+36.52% 35TCr
-0.79%+2.64%+19.18%+24.76% 27TCr
+0.58%+6.31%+9.69%+14.26% 26TCr
+1.55%+2.20%+39.81%+46.55% 21TCr
+0.79%-1.66%-23.80%-57.76% 19TCr
-0.52%+4.45%+32.12%+98.51% 19TCr
Average +0.55%+2.17%+22.66%+51.03% 36.06TCr
Weighted average by Cap. +0.19%+2.62%+35.32%+61.44%

Financials

2026 *2027 *
Net sales 285.66Cr 29Cr 25Cr 24Cr 22Cr 41Cr 2.78TCr 41Cr 110.23Cr 1.41TCr 108.8Cr 106.39Cr 4.55TCr 374.78Cr 38Cr 33Cr 31Cr 28Cr 53Cr 3.65TCr 53Cr 144.63Cr 1.85TCr 142.75Cr 139.58Cr 5.96TCr
Net income 98Cr 9.91Cr 8.64Cr 8.16Cr 7.41Cr 14Cr 951.24Cr 14Cr 38Cr 483.62Cr 37Cr 36Cr 1.56TCr 137.19Cr 14Cr 12Cr 11Cr 10Cr 19Cr 1.33TCr 20Cr 53Cr 678.6Cr 52Cr 51Cr 2.18TCr
Net Debt -451.72Cr -46Cr -40Cr -38Cr -34Cr -64Cr -4.39TCr -64Cr -174.32Cr -2.23TCr -172.05Cr -168.23Cr -7.19TCr -580.71Cr -59Cr -51Cr -48Cr -44Cr -82Cr -5.65TCr -83Cr -224.09Cr -2.87TCr -221.18Cr -216.27Cr -9.24TCr
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
18/26/18 SEK 604.00 +2.98% 2,04,289
17/26/17 SEK 586.50 +1.65% 43,094
16/26/16 SEK 577.00 -3.19% 1,12,612
15/26/15 SEK 596.00 +0.34% 55,736
14/26/14 SEK 594.00 +1.71% 48,699
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
586.50SEK
Average target price
793.00SEK
Spread / Average Target
+35.21%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!